Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoheart: Endotoxin Effects on Cardiovascular Inflammation
NCT03623022Phase 1Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2018
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Clinical Center Reference Endotoxin, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Left Ventricular Strain at 4 hours. Started Oct 2018; status: completed.
02
Drugs
Clinical Center Reference Endotoxin
Beyond the preview
Go deeper on NCT03623022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03623022.